ImmuneOnco Biopharmaceuticals (Shanghai) (R9Z.F) Q3 2025 Earnings

25AugConfirmed
Q3 2024
Q1 2025
Q3 2025
-0.05
-0.05
-0.05
-0.04

Details

Expected EPS
N/A
Actual EPS
-0.04445128015
Surprise EPS
-0.04
Surprise Percent
+∞%

Description

ImmuneOnco Biopharmaceuticals (Shanghai) (R9Z.F) has reported earnings of -0.04445128015 per share for Q3 2025.

0 Comments

Share your thoughts